Kee Song Bio-Technology Holdings (ROCO:1258) Net Income (Continuing Operations) : NT$130 Mil (TTM As of Mar. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Kee Song Bio-Technology Holdings Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Kee Song Bio-Technology Holdings's Net Income (Continuing Operations) for the three months ended in Mar. 2023 was NT$54 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2023 was NT$130 Mil.

Kee Song Bio-Technology Holdings Net Income (Continuing Operations) Historical Data

The historical data trend for Kee Song Bio-Technology Holdings's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kee Song Bio-Technology Holdings Net Income (Continuing Operations) Chart

Kee Song Bio-Technology Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-155.44

-162.96

-35.76

79.09

94.64

Kee Song Bio-Technology Holdings Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Net Income (Continuing Operations)	Get a 7-Day Free Trial															18.83	47.86	-47.70	75.65	53.85

Kee Song Bio-Technology Holdings Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$130 Mil.

Kee Song Bio-Technology Holdings (ROCO:1258) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Kee Song Bio-Technology Holdings Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Kee Song Bio-Technology Holdings's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Kee Song Bio-Technology Holdings (ROCO:1258) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kee Song Bio-Technology Holdings Ltd (ROCO:1258) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Songjiang Road, 104, 8th Floor, No. 51, Zhongshan District, Taipei, TWN, 104

Website

https://www.keesongbiotech.com

Kee Song Bio-Technology Holdings Ltd is engaged in the processing and distribution of meat products. This includes poultry, production, and sale of chicken as well as the trade of frozen meat and prepared food. It has two reportable segments; the Poultry and processing distribution segment which is engaged in the business of importing, slaughtering, wholesaling, and retailing poultry and consumable goods of all kinds; and the Poultry farming segment involved in the business of poultry farming. It derives a majority of its revenue from the poultry farming segment.

Kee Song Bio-Technology Holdings (ROCO:1258) Headlines

No Headlines